Format

Send to

Choose Destination
J Thorac Oncol. 2019 Mar;14(3):e45-e48. doi: 10.1016/j.jtho.2018.11.031. Epub 2018 Dec 10.

Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.

Author information

1
Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
2
Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
3
Resolution Bioscience, Bellevue, Washington.
4
Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee.
5
Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Electronic address: christine.lovly@vumc.org.
PMID:
30543839
PMCID:
PMC6382512
[Available on 2020-03-01]
DOI:
10.1016/j.jtho.2018.11.031
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center